Research Alert: SoundView Technology Group Issues NXT-ID (NASDAQ: NXTD) Update; Wocket Working Towards CES

BOSTON - December 3, 2014 (Investorideas.com Newswire) SoundView Technology Group (http://soundview.co) releases the following market and company update for NXT-ID, Inc. (NASDAQ: NXTD).

Market & Company Update

WOCKET WORKING TOWARDS CES
KRIS TUTTLE – DECEMBER 1, 2014

Investors have come to realize that the "revolutionary" Apple Pay is a continuation of the existing credit/debit card model and payment infrastructure. It adds a layer of security and convenience but the back end is still the same. In other words, we are digitizing the plastic part of the existing payment system rather than doing something profoundly new and different.

Biotech News Alert: GenSpera, Inc. (OTCQB:GNSZ) Featured in TheStockRadio.com Interview

SAN ANTONIO - December 2, 2014 (Investorideas.com Biotech Newswire) GenSpera, Inc. (OTCQB:GNSZ), a leader in developing innovative prodrug therapeutics for the treatment of cancer, releases a recent audio interview with TheStockRadio.com. Craig Dionne, PhD, GenSpera's CEO, discusses the company's background and history including the inception and development of the company's lead compound, mipsagargin, at John Hopkins University and its subsequent development by the company. Dr. Dionne also highlights the benefits of mipsagargin over traditional chemotherapeutics, including its limited side effects and more effective tumor killing properties.

Finally, Dr. Dionne provides an update as to the company's current Phase II clinical trials in liver cancer and glioblastoma (brain cancer) as well as future Phase II clinical trials in prostate cancer and kidney cancer and possibly even lung and breast cancers that have metastasized to the brain.

Medical Technology Breaking News: Aethlon Medical (OTCBB: AEMD) Reports Rapid and Sustained Virologic Response Rates in Hepatitis C (HCV) Treated Patients

SAN DIEGO - December 2, 2014 (Investorideas.com newswire) Aethlon Medical, Inc. (OTCBB:AEMD), the pioneer in developing targeted therapeutic devices to address infectious disease and cancer, today reported final clinical outcomes, including rapid virologic response (RVR) and sustained virologic response (SVR) rates, in Hepatitis-C virus (HCV) infected individuals who received Hemopurifier® therapy during a clinical study conducted at the Medanta Medicity Institute in India. Aethlon is now preparing to launch its first human clinical studies in the United States.

Media Alert: NXT-ID Inc. (NASDAQ: NXTD) Releases New Video, "Experience the Wocket Smart Wallet at CES 2015"

SHELTON, Conn. - December 1, 2014 (Investorideas.com Newswire) NXT-ID, Inc., (NASDAQ: NXTD) ("NXT-ID" or the "Company"), a biometric authentication company focused on the growing mobile commerce market releases the new updated video , "Experience the Wocket Smart Wallet at CES 2015".

The new updated video expands on the currently airing 30 second CNBC ads, demonstrating a purchase with a Wocket. Separate from a smartphone, Wocket allows users to choose from debit, credit and gift cards, all biometrically secured and easy to use.

NXT-ID is presenting its Wocket smart wallet at the 2015 International CES (Consumer Electronics Show) in Las Vegas, January 6-9, 2015. The Company will be located at booth 219267 in the South Hall lower level. The Company will also host a media and consumer party at CES.